Adjuvant radiotherapy and chemotherapy offer a recurrence and survival benefit in patients with resected perihilar cholangiocarcinoma.
Jung Ho ImGi Hong ChoiWoo Jung LeeDai Hoon HanSeung Woo ParkSeungmin BangHye Jin ChoiJinsil SeongPublished in: Journal of cancer research and clinical oncology (2021)
Our data suggest that adjuvant chemoradiotherapy might be considered for PHC patients with R1 resection. Adjuvant chemotherapy or chemoradiotherapy is suggested for stage III-IVA patients with R0 resection. The results of this study require validation through further prospective studies.